Publications by authors named "Alessandro Scapozza"

Claim this Profile
S
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.
Camila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, Carolina DiBenedetto, Pedro J Salaberry, Alessandro Scapozza

Cell Mol Life Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.
Denise Paula Muñoz, Camila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, Carolina DiBenedetto, Alessandro Scapozza

Res Sq· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the First Efficacious Adenosine 2A Receptor Negative Allosteric Modulators for High Adenosine Cancer Immunotherapies.
Margot Boujut, Margaux Héritier, Aurélie Gouiller, Camille Süess, Alessandro Scapozza, Leonardo Scapozza

J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.
Camila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman, Carolina DiBenedetto, Yizhuo Shen, Alessandro Scapozza

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis